Dennis Matheis insider trades
Open-market stock purchases and sales by Dennis Matheis, Director at Lucid Diagnostics Inc, from SEC Form 4 filings since Aug 18, 2020.
Track record: 0% of 8 scored buys are up 5% or more since purchase, averaging -29%.
Open-market stock purchases and sales by Dennis Matheis, Director at Lucid Diagnostics Inc, from SEC Form 4 filings since Aug 18, 2020.
Track record: 0% of 8 scored buys are up 5% or more since purchase, averaging -29%.